Literature DB >> 11585675

Mouse models of abnormal skeletal development and homeostasis.

W McLean1, B R Olsen.   

Abstract

Studies of a number of mouse mutations with skeletal defects have contributed significantly to the understanding of bone development and homeostasis. In many cases, such mutants are also genetic models of disorders in humans, characterized by reduced bone mass (osteoporosis), increased bone mass (osteopetrosis), or abnormalities in endochondral ossification (chondrodysplasias).

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11585675     DOI： 10.1016/s0168-9525(01)02458-1

Source DB:  PubMed          Journal:  Trends Genet        ISSN： 0168-9525            Impact factor:   11.639


  11 in total

1.  Human stanniocalcin-1 or -2 expressed in mice reduces bone size and severely inhibits cranial intramembranous bone growth.

Authors:  Jennifer Johnston; Yudith Ramos-Valdes; Lee-Anne Stanton; Sadia Ladhani; Frank Beier; Gabriel E Dimattia
Journal:  Transgenic Res       Date:  2010-02-20       Impact factor: 2.788

2.  A role for a lithium-inhibited Golgi nucleotidase in skeletal development and sulfation.

Authors:  Joshua P Frederick; A Tsahai Tafari; Sheue-Mei Wu; Louis C Megosh; Shean-Tai Chiou; Ryan P Irving; John D York
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-11       Impact factor: 11.205

3.  In vivo delivery of fluoresceinated dextrans to the murine growth plate: imaging of three vascular routes by multiphoton microscopy.

Authors:  Cornelia E Farnum; Michelle Lenox; Warren Zipfel; William Horton; Rebecca Williams
Journal:  Anat Rec A Discov Mol Cell Evol Biol       Date:  2006-01

4.  Recurrent mutation of the gene encoding sequestosome 1 (SQSTM1/p62) in Paget disease of bone.

Authors:  Nancy Laurin; Jacques P Brown; Jean Morissette; Vincent Raymond
Journal:  Am J Hum Genet       Date:  2002-04-30       Impact factor: 11.025

5.  FGF18 is required for normal cell proliferation and differentiation during osteogenesis and chondrogenesis.

Authors:  Norihiko Ohbayashi; Masaki Shibayama; Yoko Kurotaki; Mayumi Imanishi; Toshihiko Fujimori; Nobuyuki Itoh; Shinji Takada
Journal:  Genes Dev       Date:  2002-04-01       Impact factor: 11.361

6.  A new osteopetrosis mutant mouse strain (ntl) with odontoma-like proliferations and lack of tooth roots.

Authors:  Xincheng Lu; Hector F Rios; Baichun Jiang; Lianping Xing; Renata Kadlcek; Edward M Greenfield; Guangbin Luo; Jian Q Feng
Journal:  Eur J Oral Sci       Date:  2009-12       Impact factor: 2.612

7.  Progressive skeletal defects caused by Kindlin3 deficiency, a model of autosomal recessive osteopetrosis in humans.

Authors:  Tejasvi Dudiki; Daniel W Nascimento; Lauren S Childs; Swetha Kareti; Charlie Androjna; Irina Zhevlakova; Tatiana V Byzova
Journal:  Bone       Date:  2022-03-25       Impact factor: 4.626

8.  Osteopenia in Sparc (osteonectin)-deficient mice: characterization of phenotypic determinants of femoral strength and changes in gene expression.

Authors:  Fiona C Mansergh; Timothy Wells; Carole Elford; Samuel L Evans; Mark J Perry; Martin J Evans; Bronwen A J Evans
Journal:  Physiol Genomics       Date:  2007-09-18       Impact factor: 3.107

9.  Osteopetrosis and thalamic hypomyelinosis with synaptic degeneration in DAP12-deficient mice.

Authors:  Tomonori Kaifu; Jin Nakahara; Masanori Inui; Kenichi Mishima; Toshihiko Momiyama; Mitsuji Kaji; Akiko Sugahara; Hisami Koito; Azusa Ujike-Asai; Akira Nakamura; Kiyoshi Kanazawa; Kyoko Tan-Takeuchi; Katsunori Iwasaki; Wayne M Yokoyama; Akira Kudo; Michihiro Fujiwara; Hiroaki Asou; Toshiyuki Takai
Journal:  J Clin Invest       Date:  2003-02       Impact factor: 14.808

10.  Inherited CHST11/MIR3922 deletion is associated with a novel recessive syndrome presenting with skeletal malformation and malignant lymphoproliferative disease.

Authors:  Sameer S Chopra; Ignaty Leshchiner; Hatice Duzkale; Heather McLaughlin; Monica Giovanni; Chengsheng Zhang; Nathan Stitziel; Joyce Fingeroth; Robin M Joyce; Matthew Lebo; Heidi Rehm; Dana Vuzman; Richard Maas; Shamil R Sunyaev; Michael Murray; Christopher A Cassa
Journal:  Mol Genet Genomic Med       Date:  2015-05-10       Impact factor: 2.183
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.